Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response.

Eickhoff J, Hanke M, Stein-Gerlach M, Kiang TP, Herzberger K, Habenberger P, Müller S, Klebl B, Marschall M, Stamminger T, Cotten M.

J Biol Chem. 2004 Mar 5;279(10):9642-52. Epub 2003 Dec 10.

2.

Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells.

Caposio P, Luganini A, Hahn G, Landolfo S, Gribaudo G.

Cell Microbiol. 2007 Aug;9(8):2040-54. Epub 2007 Apr 5.

PMID:
17419715
3.

Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells.

Caposio P, Musso T, Luganini A, Inoue H, Gariglio M, Landolfo S, Gribaudo G.

Antiviral Res. 2007 Mar;73(3):175-84. Epub 2006 Oct 23.

PMID:
17070604
4.

NF-kappaB activation can mediate inhibition of human cytomegalovirus replication.

Eickhoff JE, Cotten M.

J Gen Virol. 2005 Feb;86(Pt 2):285-95.

PMID:
15659747
5.

Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication.

Kapoor A, Forman M, Arav-Boger R.

PLoS One. 2014 Mar 26;9(3):e92704. doi: 10.1371/journal.pone.0092704. eCollection 2014.

6.

Human cytomegalovirus circumvents NF-kappa B dependence in retinal pigment epithelial cells.

Cinatl J Jr, Margraf S, Vogel JU, Scholz M, Cinatl J, Doerr HW.

J Immunol. 2001 Aug 15;167(4):1900-8. Erratum in: J Immunol 2001 Oct 15;167(8):following 4770.

7.

An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways.

Inohara N, Koseki T, Lin J, del Peso L, Lucas PC, Chen FF, Ogura Y, Núñez G.

J Biol Chem. 2000 Sep 8;275(36):27823-31.

8.
9.

Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease.

Hollenbach E, Vieth M, Roessner A, Neumann M, Malfertheiner P, Naumann M.

J Biol Chem. 2005 Apr 15;280(15):14981-8. Epub 2005 Feb 3.

10.

Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent Pathway.

Kapoor A, Fan YH, Arav-Boger R.

Sci Rep. 2016 Feb 2;6:20295. doi: 10.1038/srep20295.

12.

CARD6 is a modulator of NF-kappa B activation by Nod1- and Cardiak-mediated pathways.

Stehlik C, Hayashi H, Pio F, Godzik A, Reed JC.

J Biol Chem. 2003 Aug 22;278(34):31941-9. Epub 2003 May 29.

13.

Human cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1beta-mediated NF-kappaB signaling.

Montag C, Wagner J, Gruska I, Hagemeier C.

J Virol. 2006 Dec;80(23):11686-98. Epub 2006 Sep 27.

14.

Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB.

Prösch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk HD, Krüger DH.

Virology. 1995 Apr 1;208(1):197-206.

15.
16.

Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity.

Kitagawa R, Takahashi Y, Takahashi M, Imazu H, Yasuda M, Sadanari H, Tanaka J.

Virology. 2009 Jan 20;383(2):195-206. doi: 10.1016/j.virol.2008.10.028. Epub 2008 Nov 22.

17.

The human cytomegalovirus UL26 protein antagonizes NF-κB activation.

Mathers C, Schafer X, Martínez-Sobrido L, Munger J.

J Virol. 2014 Dec;88(24):14289-300. doi: 10.1128/JVI.02552-14. Epub 2014 Oct 1.

18.

A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2.

Khursigara G, Bertin J, Yano H, Moffett H, DiStefano PS, Chao MV.

J Neurosci. 2001 Aug 15;21(16):5854-63.

19.

Protein kinase C-associated kinase (PKK) mediates Bcl10-independent NF-kappa B activation induced by phorbol ester.

Muto A, Ruland J, McAllister-Lucas LM, Lucas PC, Yamaoka S, Chen FF, Lin A, Mak TW, Núñez G, Inohara N.

J Biol Chem. 2002 Aug 30;277(35):31871-6. Epub 2002 Jun 28.

20.

RIP2-beta: a novel alternative mRNA splice variant of the receptor interacting protein kinase RIP2.

Krieg A, Le Negrate G, Reed JC.

Mol Immunol. 2009 Mar;46(6):1163-70. doi: 10.1016/j.molimm.2008.11.002. Epub 2009 Jan 3.

PMID:
19121870

Supplemental Content

Support Center